$1.23
0.021.65%
At close: -
$1.25
0.021.63%
After Hours: Jan 23, 7:54 AM EDT
Comments
Loading...
Plus Therapeutics (NASDAQ:PSTV) Stock, Earnings Estimates, EPS, And Revenue
Plus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 4
EPS Estimate
$-0.510
Quarterly Revenue Estimate
$1.19M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Plus Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Plus Therapeutics (PSTV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.37 | $-0.56 | 33.9 % |
| Q2 | 2024-08-14 | $-0.71 | $-0.53 | -34.0 % |
| Q1 | 2024-05-15 | $-0.75 | $-1.09 | 31.2 % |
| Q4 | 2024-03-05 | $-0.70 | $-1.07 | 34.6 % |
Plus Therapeutics (PSTV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $1.46M | $1.14M | 27.7 % |
| Q2 | 2024-08-14 | $1.28M | $1.67M | -23.4 % |
| Q1 | 2024-05-15 | $1.68M | $1.69M | -0.77 % |
| Q4 | 2024-03-05 | $1.31M | $1.06M | 23.9 % |
FAQ
When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?
Plus Therapeutics (PSTV) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Plus Therapeutics (NASDAQ:PSTV)?
The Actual EPS was $-0.37, which beat the estimate of $-0.56.
What were Plus Therapeutics’s (NASDAQ:PSTV) revenues?
The Actual Revenue was $1.5M, which beat the estimate of $1.1M.
Browse earnings estimates, EPS, and revenue on all stocks.